660 related articles for article (PubMed ID: 24952258)
1. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S
Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.
Chen J; Wang L; Matyunina LV; Hill CG; McDonald JF
Gynecol Oncol; 2011 Apr; 121(1):200-5. PubMed ID: 21277012
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-429 functions as a regulator of epithelial-mesenchymal transition by targeting Pcdh8 during murine embryo implantation.
Li Z; Gou J; Jia J; Zhao X
Hum Reprod; 2015 Mar; 30(3):507-18. PubMed ID: 25609238
[TBL] [Abstract][Full Text] [Related]
7. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
8. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.
Zhang M; Jabbari N; Satpathy M; Matyunina LV; Wang Y; McDonald LD; McDonald JF
Cancer Lett; 2019 Sep; 459():168-175. PubMed ID: 31163194
[TBL] [Abstract][Full Text] [Related]
9. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
[TBL] [Abstract][Full Text] [Related]
10. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
11. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
13. Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
Wang L; Mezencev R; Švajdler M; Benigno BB; McDonald JF
Gynecol Oncol; 2014 Jul; 134(1):96-103. PubMed ID: 24802724
[TBL] [Abstract][Full Text] [Related]
14. The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
Choi PW; Ng SW
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587302
[TBL] [Abstract][Full Text] [Related]
15. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
[TBL] [Abstract][Full Text] [Related]
16. The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells.
Brozovic A; Duran GE; Wang YC; Francisco EB; Sikic BI
Mol Oncol; 2015 Oct; 9(8):1678-93. PubMed ID: 26025631
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-200 family: still much to discover.
Senfter D; Madlener S; Krupitza G; Mader RM
Biomol Concepts; 2016 Dec; 7(5-6):311-319. PubMed ID: 27837593
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
19. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.
Bai JX; Yan B; Zhao ZN; Xiao X; Qin WW; Zhang R; Jia LT; Meng YL; Jin BQ; Fan DM; Wang T; Yang AG
Endocrinology; 2013 Feb; 154(2):635-45. PubMed ID: 23295740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
